Cargando…
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
Neuromyelitis optica spectrum disorder (NMOSD) is a severe inflammatory autoimmune disease that mainly involves the optic nerves and spinal cord, causing blindness and paralysis. Although some immunosuppressants such as rituximab and azathioprine have proven to be effective in relapse prevention, th...
Autores principales: | Chen, Bo, Wu, Qian, Ke, Gaotan, Bu, Bitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429791/ https://www.ncbi.nlm.nih.gov/pubmed/28400553 http://dx.doi.org/10.1038/s41598-017-00860-y |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
por: Fan, Moli, et al.
Publicado: (2020) -
Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)